Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits-Reference-Cited by-同舟云学术

Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits

Published:2019-04 Issue:1 Volume:153 Page:192-200
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Gordhandas Sushmita,Norquist Barbara M.,Pennington Kathryn P.,Yung Rachel L.,Laya Mary B.,Swisher Elizabeth M.^ORCID

Funder

Stand Up To Cancer

Ovarian Cancer Research Fund Alliance

National Ovarian Cancer Coalition

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference56 articles.

1. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers;Kuchenbaecker;JAMA,2017

2. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies;Antoniou;Am. J. Hum. Genet.,2003

3. NCCN guidelines insights: genetic/familial high-risk assessment: breast and ovarian, version 2.2017;Daly;J. Natl. Compr. Cancer Netw.,2017

4. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality;Domchek;JAMA,2010

5. Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation;Finch;J. Clin. Oncol.,2014

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Hormonal Replacement Therapy and Mindfulness-Based Stress Reduction on Climacteric Symptoms Following Risk-Reducing Salpingo-Oophorectomy;Healthcare;2024-08-13

2. Prevention of Ovarian Cancer: Where are We Now and Where are We Going?;Current Oncology Reports;2024-08-08

3. Sexual Function in Women Diagnosed with Hereditary Breast and Ovarian Cancer Syndrome;Cancers;2024-07-21

4. Basic knowledge for counseling patients undergoing risk-reducing salpingo-oophorectomy;Obstetrics & Gynecology Science;2024-07-15

5. Information needs of Lynch syndrome and BRCA 1/2 mutation carriers considering risk-reducing gynecological surgery: a qualitative study of the decision-making process;Hereditary Cancer in Clinical Practice;2024-05-02